Wardex Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Madras-29, Tamil Nadu, India, established in 1946.
1946 Madras-29, Tamil Nadu, India Active
Last Updated:
Access Report
About Wardex Pharmaceuticals Private Limited

Wardex Pharmaceuticals Private Limited, a active private limited company, was established on 18 December 1946 in Madras-29, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51397TN1946PTC005759. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹4.20 M.

Formerly known as Ward Blenkinsop & Co. (India) Private Limited, Ward Blenkinsop & Co. (India) Limited. It upholds a compliant status. Employing 102 professional, Its leadership includes Errol James Desouza (Additional Director), Jagdish Purushottamdas Mehta (Director), Syed Asif Raza Rizvi (Director). Past directors included Manik Lal Saha, Noel Christopher Amanna, Ugra Sen Singh. It holds ₹3.00 M open charges and ₹1.64 Cr settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at 55,Nelson Manicka Mudaliarroad,Aminjikarai, Madras-29, Madras-29, Tamil Nadu, 600029.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397TN1946PTC005759

  • Registration Number

    005759

  • Incorporation Date

    18 December 1946

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹4.20 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 4.20 M
  • Company Age 79 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.00 M
  • Satisfied Charges ₹ 1.64 Cr
  • Revenue Growth **** 3.49%
  • Profit Growth **** 38.87%
  • Ebitda **** 14.05%
  • Net Worth 1.20%
  • Total Assets **** 11.60%
Company report

Wardex Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Wardex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Wardex Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Errol James Desouza Additional Director 28 Jan 2025 Current
Jagdish Purushottamdas Mehta Director 19 Mar 2014 Current
Syed Asif Raza Rizvi Director 26 Feb 2021 Current
Vitalapuram Rajangam Krishna Subramanian Director 01 Feb 1999 Current
Venkatraman Subramaniam Director 27 Jan 2018 Current
Pascal Postel Director 31 Dec 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Apr 2014 Past
Pramod Abcsdd Director 23 Feb 2021 Past
Pramod Abcsdd Director 29 May 2017 Past
Pramod Abcsdd Director 02 May 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2014 Past
Pramod Abcsdd Additional Director 26 Nov 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Wardex Pharmaceuticals.

Wardex Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 3.49% increase. The company also saw a substantial improvement in profitability, with a 38.87% increase in profit. The company's net worth moved up by a moderate rise of 1.2%.

Wardex Pharmaceuticals revenue growth over time
Wardex Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.49%
*******
*******
*******
*******
Revenue from Operations
*******
 2.22%
*******
*******
*******
*******
Total Assets
*******
 11.60%
*******
*******
*******
*******
Profit or Loss
*******
 38.87%
*******
*******
*******
*******
Net Worth
*******
 1.20%
*******
*******
*******
*******
EBITDA
*******
 14.05%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Wardex Pharmaceuticals?

In 2024, Wardex Pharmaceuticals had a public holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,000,000.00

Satisfied Charges

₹16,400,000.00

Charges Breakdown by Lending Institutions
  • Catholic Syrian Bank Ltd. : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
21 Dec 1982 Catholic Syrian Bank Ltd. ₹3.00 M Open
26 Sep 2014 Bnp Paribas ₹7.50 M Satisfied
20 Sep 1996 Banque Nationale De Paris ₹6.90 M Satisfied
10 Nov 1978 Banque Natinale De Paris ₹2.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Wardex Pharmaceuticals?

Wardex Pharmaceuticals has a workforce of 102 employees as of Aug 30, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Wardex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wardex Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Wardex Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge registered on 26 Sep 2014 via Charge ID 10524177 with Bnp Paribas was fully satisfied on 22 Apr 2025. was recorded as a recent event.

  • Charges

    The activity A charge registered on 20 Sep 1996 via Charge ID 90300649 with Banque Nationale De Paris was fully satisfied on 22 Apr 2025. was completed.

  • Charges

    A charge registered on 10 Nov 1978 via Charge ID 90299117 with Banque Natinale De Paris was fully satisfied on 22 Apr 2025. was recorded as a recent event.

  • Director Appointment

    Progress on Errol James Desouza was appointed as a Additional Director was appointed as a Additional Director on 28 Jan 2025 & has been associated with this company since 1 year 3 months . was documented.

  • Annual General Meeting

    Progress on Wardex Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Wardex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Wardex Pharmaceuticals Private Limited?

The CIN of Wardex Pharmaceuticals Private Limited is U51397TN1946PTC005759.

Where is Wardex Pharmaceuticals Private Limited headquartered?

Wardex Pharmaceuticals Private Limited is headquartered at 55,Nelson Manicka Mudaliarroad,Aminjikarai, Madras-29, Madras-29, Tamil Nadu, 600029.

When was Wardex Pharmaceuticals Private Limited incorporated?

Wardex Pharmaceuticals Private Limited was incorporated on 18 December 1946.

Who are the current directors of Wardex Pharmaceuticals Private Limited?

The current directors of Wardex Pharmaceuticals Private Limited are

What is the primary industry of Wardex Pharmaceuticals Private Limited?

The primary industry of Wardex Pharmaceuticals Private Limited is Manufacturing.

Is Wardex Pharmaceuticals Private Limited a listed company?

Wardex Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Wardex Pharmaceuticals Private Limited?

The authorized capital of Wardex Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹4.20 M.

What is the compliance status of Wardex Pharmaceuticals Private Limited?

The compliance status of Wardex Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available